Rechercher dans ce blog

Sunday, July 28, 2019

Pfizer and Mylan set to merge off-patent drugs businesses - Financial Times

Pfizer and Mylan set to merge off-patent drugs businesses  Financial Times

Pfizer is expected to announce on Monday that it will combine its off-patent drug business with Mylan, the generics drugmaker with a market value of $9.5bn, ...


Pfizer and Mylan set to merge off-patent drugs businesses - Financial Times
Read More

No comments:

Post a Comment

Search

Featured Post

5 key takeaways from Xi's trip to Saudi Arabia - CNN

Editor’s Note: A version of this story appears in CNN’s Meanwhile in today’s Middle East newsletter, a three-times-a-week look inside the r...

Postingan Populer